Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (25)

« Back to Publications

Novel way of displaying Delphi responses when collecting through the REDCap data collection system.

Barber VS. et al, (2026), Trials, 27

Antimicrobial-impregnated urinary catheters against urinary tract infection for long-term indwelling urinary catheter users: lessons from the CAUTI RCT

Bayston R. et al, (2025), Efficacy and Mechanism Evaluation, 1 - 18

andomised SWAT assessing the impact of an enhanced patient information leaflet on recruitment in a trial of axillary treatment for early-stage breast cancer

Bruce C. et al, (2025), F1000Research, 14, 1145 - 1145

Developing generic clinical trial animated explainer videos in the UK: results of a survey and case study.

Calvert C. et al, (2025), Trials, 26

Current usage of explainer animations in trials: a survey of the UKCRC registered clinical trial units in the UK.

Barber VS. et al, (2024), Trials, 25

Protocol for open-label randomized clinical trial of intensive surveillance versus standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer.

Markar SR. et al, (2023), Br J Surg, 110, 1359 - 1360

Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial.

Ross JDC. et al, (2023), BMC Womens Health, 23

The DEVA trial: protocol for a randomised controlled trial of dequalinium chloride versus usual care antibiotics for the treatment of bacterial vaginosis.

Haydock R. et al, (2022), Trials, 23

Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial

ROSS JDC. et al, (2022)

Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: the VITA RCT.

Armstrong-Buisseret L. et al, (2022), Health Technol Assess, 26, 1 - 170

POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes.

Goyal A. et al, (2021), BMJ Open, 11

Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcome.

Cole MJ. et al, (2020), J Antimicrob Chemother, 75, 449 - 457

Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis.

Armstrong-Buisseret L. et al, (2019), Trials, 20

Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.

Ross JDC. et al, (2019), Lancet, 393, 2511 - 2520

Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT.

Ross JD. et al, (2019), Health Technol Assess, 23, 1 - 104

Load More